EnzeneX™ 2.0 and the power of Fully-Connected Continuous Manufacturing™: Driving down mAb costs to $40/gram
Conference Dates
October 5-9, 2025
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Arindam Chakraborty, "EnzeneX™ 2.0 and the power of Fully-Connected Continuous Manufacturing™: Driving down mAb costs to $40/gram" in "Integrated Continuous Biomanufacturing VII (ICB VII)", Irina Ramos, AstraZeneca; Mark Brower, Merck; Alois Jungbauer, BOKU; K. Brower, Sanofi Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/biomanufact_vii/5
109.pdf (71 kB)
COinS